Included with registration, selections made during registration process (non-cme events).


Thursday, March 10, 6:45-8:00 AM (non-CME)

B1 – Nova Breakfast Symposium
Sponsored by: Nova Biomedical
1. The importance of proper electrolyte management in CRRT: Measuring iMg, iCa and electrolytes with a point-of-care analyzer (20 minutes)
Dr. Thiago Reis
Department of Nephrology, Clinica de Doenças Renais de Brasilia, Brasilia, Brazil

2. Options for outpatient follow-up after AKI admission (15 minutes)
Dr. Dennis Begos
Medical Director, Nova Biomedical

3. Estimated plasma volume and its use in CRRT (15 minutes)
Dr. Rubens Lodi
Medical Director, Nova Biomedical

4. Early diagnosis and screening for AKI/CKD using a portable meter (15 minutes)
Dr. Naveen Bangia
Medical Director, Nova Biomedical


Tuesday, March 8, 12:30-2:00 PM (non-CME)

I1 – Real-Time Renal Function Meets Digital Medicine
Sponsored by: Renal Sense
Real-time urine output as an early indicator of renal function and AKI risk is the most vital physiological parameter that still involves manual recordings in the critical care setting. This symposium will discuss the clinical value of electronic monitoring of real-time urine flow in critical care patients.
Moderator: Jay Koyner, MD

1. Oliguria in the ICU, what does it really mean and how good are we at detecting it? – John Kellum, MD
2. Real-time urine flow monitoring: impact on management of high-risk surgical patients – Jacques Duranteau, MD, PhD
3. Oliguria: An Inexpensive and Impactful Urine Biomarker – Stuart Goldstein, MD

Tuesday, March 8, 12:30-2:00 PM (non-CME)

I2 – The Fresh Trial: A review of the RCT: Fluid Response Evaluation in Sepsis Hypotension and Shock
Douglas M. Hansell, MD, MPH
VP, Head of Medical Affairs Medication Delivery, Baxter Healthcare
Mass General Hosp, Boston
Sponsored by: Baxter
Discussion on the importance of a comprehensive understanding of IV fluid types, fluid physiology and evidence to support and refute fluid use in specific populations. A review of the recently published RCT and significant outcomes in Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH) study.
Objectives and Discussion:

    • What does “fluid responsive” really mean?
    • How and why is “fluid responsiveness” changing clinical practice and patient outcomes?
    • How & when should I use “fluid responsiveness” at the bedside?
    • Review different methods available for measuring fluid responsiveness
    • What are the current areas of research in fluid management?


Wednesday, March 9, 12:30-2:00 PM (non-CME)

I3 – AKI Awareness: Challenges and Opportunities
Claudio Ronco, MD, Marlies Ostermann, MD and Rajit Basu, MD
Sponsored by: bioMerieux, Inc
This expert panel session will discuss the results of a multi-national, multi-specialty survey of Healthcare Providers. HCPs agree that AKI is a contributor to patient morbidity and mortality however, there is discrepancy in the recognition of AKI, assessment of diagnostic adequacy, desire for education, use of KDIGO management guidelines, and thoughts on long-term effects.


Tuesday, March 8, 2:00-3:30pm (non-CME)

I5 – Differentiating Hemopurification Therapies – Practical Applications of Pathogen & Endotoxin Reduction
Sponsored by: Exthera Medical and Spectral Medical
2:00: Introduction (Claudio Ronco)
2:10: Pathogen Reduction via Hemoperfusion: Latest Data & Clinical Experience (Mink Chawla)
2:40: EUPHRATES to TIGRIS: Targeting Endotoxemia in Septic shock (John Kellum)
3:10: Discussion


Tuesday, March 8 (non-CME)

10:30-11:00 Coffee Break
Baxter – Starling Monitor

3:30-4:00 Coffee Break
bioMerieux, Inc – Know Earlier. Intervene Sooner. Avoid Acute Kidney Injury (AKI)

Wednesday, March 9 (non-CME)

9:45-10:15 Coffee Break
Fresenius – NxStage System One with Speedswap

3:45-4:15 Coffee Break
Medtronic – Innovations in Pediatric CRRT: Carpediem cardio-renal pediatric emergency dialysis machine demonstration